AstraZeneca Pharma India Q1 net profit declines 45% to Rs 10.24 cr

AstraZeneca Pharma India Q1 net profit declines 45% to Rs 10.24 cr

PTIUpdated: Monday, August 09, 2021, 04:27 PM IST
article-image
AstraZeneca Pharma India had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal |

Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarter.

The company had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.

Revenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago, it added.

The company's board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22, the filing said.

Shares of AstraZeneca Pharma India closed at Rs 3,364.45 per scrip on BSE, down 1.23 per cent from its previous close

RECENT STORIES

HUL Names Priya Nair As CEO & MD With Effect From August 1

HUL Names Priya Nair As CEO & MD With Effect From August 1

Canara Bank Withdraws Order Classifying Anil Ambani’s ₹1,050 Crore Loan Account As Fraudulent;...

Canara Bank Withdraws Order Classifying Anil Ambani’s ₹1,050 Crore Loan Account As Fraudulent;...

Singapore Airlines Partners With Mandai Wildlife Group To Offer Curated Wildlife Experiences And...

Singapore Airlines Partners With Mandai Wildlife Group To Offer Curated Wildlife Experiences And...

India Must Build Supply Chain Resilience In Energy Sector To Achieve Self-Reliance: Union Minister...

India Must Build Supply Chain Resilience In Energy Sector To Achieve Self-Reliance: Union Minister...

TCS Reports 6% Q1 Net Profit Rise To ₹12,760 Crore, Announces ₹11 Interim Dividend

TCS Reports 6% Q1 Net Profit Rise To ₹12,760 Crore, Announces ₹11 Interim Dividend